关键词：移植；患病；损伤；细胞；免疫抑制药物；器官保存液
摘 要：Transplantation is the procedure in which diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functions of the body. Organs such as kidneys, liver, heart, lungs, intestine, pancreas, and thymus can be transplanted. Some tissues such as cornea, bones, tendons, heart valves, skin, nerves, and veins can also be replaced. Kidney transplantation is the most frequent transplantation procedure worldwide, followed by liver and heart transplantations. Cornea and musculoskeletal graft transplantations are the most common tissue transplantation procedures.
内 容：

---

目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Overview

06.1 Organ Transplantation in Americas

06.2 Organ Transplantation in Europe

06.3 Organ Transplantation in APAC Region

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Market Segmentation by Application

09. Market Segmentation by Product Type

09.1 Global Transplantation Tissue Products Market

09.1.1 Market Size and Forecast

09.2 Global Immunosuppressant Drugs Market

09.2.1 Market Size and Forecast

09.3 Global Tissue Typing Technologies and Organ

Preservation Solutions Market

09.3.1 Market Size and Forecast

09.4 Global Alternative Technologies Market

09.4.1 Market Size and Forecast

10. Geographical Segmentation

10.1 Transplantation Market in Americas

10.1.1 Market Size and Forecast

10.2 Transplantation Market in EMEA Region

10.2.1 Market Size and Forecast

10.3 Transplantation Market in APAC Region

10.3.1 Market Size and Forecast

11. Key Leading Countries

11.1 US

11.2 UK

11.3 France

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Vendor Analysis 2014

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Abbott Laboratories

20.1.1 Key Facts

20.1.2 Business Description

20.1.3 Business Segmentation

20.1.4 Business Strategy

20.1.5 Revenue by Business Segmentation

20.1.6 Revenue Comparison 2011 and 2012

20.1.7 Revenue by Geographical Segmentation

20.1.8 Key Information

20.1.9 SWOT Analysis

20.2 Arthrex

20.2.1 Key Facts

20.2.2 Business Overview

20.2.3 Product Groups

20.2.4 Key Locations

20.2.5 Recent Developments

20.2.6 SWOT Analysis

20.3 Biomet

20.3.1 Key Facts

20.3.2 Business Overview

20.3.3 Product Segmentation by Revenue 2014

20.3.4 Product Segmentation by Revenue 2013 and 2014

20.3.5 Geographical Segmentation by Revenue 2014

20.3.6 Business Strategy

20.3.7 Recent Developments

20.3.8 SWOT Analysis

20.4 Kinetic Concepts

20.4.1 Key Facts

20.4.2 Business Overview

20.4.3 Business Segmentation

20.4.4 Business Segmentation by Revenue 2013

20.4.5 Sales by Geography

20.4.6 Business Strategy

20.4.7 Recent Developments

20.4.8 SWOT Analysis

20.5 Medtronic

20.5.1 Key Facts

20.5.2 Business Overview

20.5.3 Business Segmentation

20.5.4 Revenue by Business Segmentation

20.5.5 Revenue Comparison by Business Segmentation 2012 and

2013

20.5.6 Revenue by Geographical Segmentation

20.5.7 Business Strategy

20.5.8 Key Developments

20.5.9 SWOT Analysis

20.6 Novartis

20.6.1 Key Facts

20.6.2 Business Description

20.6.3 Business Segmentation

20.6.4 Revenue by Business Segmentation

20.6.5 Revenue Comparison 2012 and 2013

20.6.6 Sales by Geography

20.6.7 Business Strategy

20.6.8 Key Developments

20.6.9 SWOT Analysis

20.7 Stryker

20.7.1 Key Facts

20.7.2 Business Overview

20.7.3 Business Segmentation by Revenue 2013

20.7.4 Business Segmentation by Revenue 2012 and 2013

20.7.5 Geographical Segmentation by Revenue 2013

20.7.6 Business Strategy

20.7.7 Recent Developments

20.7.8 SWOT Analysis

21. Other Reports in this Series